109,954名成年起病糖尿病退伍军人中的1型糖尿病遗传风险:百万退伍军人计划(MVP)
在109,594名成年起病的糖尿病退伍军人中,1型糖尿病(T1D)特征随遗传风险评分(GRS)升高而增多;但最高风险组(≥95%)的平均年龄64.3岁、BMI 32.3 kg/m2,与2型糖尿病(T2D)患者相似,且相当比例未接受诊断检测或使用T1D诊断代码。作者认为T1D遗传筛查可有助于在T2D为主的环境中识别成年起病T1D。
要点
- T1D特征随GRS升高而逐步增多(趋势P < 0.001)。
- 最高风险组(≥95%)的平均年龄64.3岁、BMI 32.3 kg/m2,与T2D患者相似。
- 相当比例高风险者未接受诊断检测或未使用T1D诊断代码。
核心结论
- 与T1D相关的特征随遗传风险升高而增多,尤其是在风险最高的10%人群中。
- 然而这些参与者的年龄和BMI与T2D患者相似,且相当比例未接受诊断检测或使用T1D诊断代码。
- T1D遗传筛查可有助于在T2D为主的环境中识别成年起病T1D。
研究设计与样本
- 研究纳入2011-2021年百万退伍军人计划(MVP)中109,594名成年起病糖尿病参与者,均有T1D遗传风险评分(GRS)。
- GRS分为低(0至<45%)、中(45至<90%)、高(90至<95%)和最高(≥95%)四组。
主要发现
- T1D特征随遗传风险升高而逐步增多(趋势P < 0.001)。
- GRS ≥90%在40岁前诊断糖尿病者中更常见,但这些参与者中95%在≥40岁时诊断,其平均年龄64.3岁、BMI 32.3 kg/m2,与T2D患者相似。
- 与低风险组相比,最高风险组的糖尿病酮症酸中毒比例为0.9% vs 3.7%,因低血糖急诊就诊比例为3.7% vs 5.8%,门诊血糖<50 mg/dL比例为7.5% vs 13.4%,开始胰岛素治疗的中位时间3.5年 vs 1.4年,使用T1D诊断代码比例为16.3% vs 28.1%,检测时C肽水平低的比例为1.8% vs 32.4%,谷氨酸脱羧酶抗体阳性比例为6.9% vs 45.2%,所有P < 0.001。
临床怎么用
- 作者认为T1D遗传筛查可有助于在T2D为主的环境中识别成年起病T1D。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize high type 1 diabetes (T1D) genetic risk in a population where type 2 diabetes (T2D) predominates. RESEARCH DESIGN AND METHODS: Characteristics typically associated with T1D were assessed in 109,594 Million Veteran Program participants with adult-onset diabetes, 2011-2021, who had T1D genetic risk scores (GRS) defined as low (0 to <45%), medium (45 to <90%), high (90 to <95%), or highest (≥95%). RESULTS: T1D characteristics increased progressively with higher genetic risk (P < 0.001 for trend). A GRS ≥90% was more common with diabetes diagnoses before age 40 years, but 95% of those participants were diagnosed at age ≥40 years, and their characteristics resembled those of individuals with T2D in mean age (64.3 years) and BMI (32.3 kg/m2). Compared with the low-risk group, the highest-risk group was more likely to have diabetic ketoacidosis (low GRS 0.9% vs. highest GRS 3.7%), hypoglycemia prompting emergency visits (3.7% vs. 5.8%), outpatient plasma glucose <50 mg/dL (7.5% vs. 13.4%), a shorter median time to start insulin (3.5 vs. 1.4 years), use of a T1D diagnostic code (16.3% vs. 28.1%), low C-peptide levels if tested (1.8% vs. 32.4%), and glutamic acid decarboxylase antibodies (6.9% vs. 45.2%), all P < 0.001. CONCLUSIONS: Characteristics associated with T1D were increased with higher genetic risk, and especially with the top 10% of risk. However, the age and BMI of those participants resemble those of people with T2D, and a substantial proportion did not have diagnostic testing or use of T1D diagnostic codes. T1D genetic screening could be used to aid identification of adult-onset T1D in settings in which T2D predominates.
引用
- Yang PK, Jackson SL, Charest BR, et al. Type 1 Diabetes Genetic Risk in 109,954 Veterans With Adult-Onset Diabetes: The Million Veteran Program (MVP). Diabetes Care. 2024. PMID: 38608262. doi:10.2337/dc23-1927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。